Overview

Efficacy and Safety of Acetaminophen, Aspirin and Caffeine With Sumatriptan in the Acute Treatment of Migraine

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the efficacy and safety of aspirin, acetaminophen and caffeine (AAC) with sumatriptan and placebo in the acute treatment of migraine.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Acetaminophen
Aspirin
Caffeine
Sumatriptan